Longdom Conferences

Speaker

Sep 05-06, 2022    London, UK
International conference on

Microfluidics and Nanofluidics

Farah El Masri
10:20 AM-10:40 AM

Farah El Masri

Duabi

Title:

Biography:

Farah is an associate in the Firm's Dubai office. Farah is a corporate lawyer with a focus on mergers and acquisitions, joint ventures and restructurings, as well as general corporate and compliance matters. Farah is qualified in England & Wales.

Useful Links

News

A sound approach to advancing healthcare systems: the future of biomedical acoustics

2022-07-05 - 2022-07

Newly developed acoustic technologies are playing a transformational role in life science and biomedical applications ranging from the activation and inactivation of mechanosensitive ion channels for fundamental physiological processes to the development of contact-free, precise biofabrication protocols for tissue engineering and large-scale manufacturing of organoids.

Microfluidics for understanding model organisms

2022-07-05 - 2022-07

New microfluidic systems for whole organism analysis and experimentation are catalyzing biological breakthroughs across many fields, from human health to fundamental biology principles.

Geometric structure design of passive label-free microfluidic systems for biological micro-object separation

2022-07-05 - 2022-07

Passive and label-free microfluidic devices have no complex external accessories or detection-interfering label particles. These devices are now widely used in medical and bioresearch applications, including cell focusing and cell separation.

A role for microfluidic systems in precision medicine

2022-07-05 - 2022-07

Precision oncology continues to challenge the “one-size-fits-all” dogma. Under the precision oncology banner, cancer patients are screened for molecular tumor alterations that predict treatment response, ideally leading to optimal treatments.

High throughput, label-free isolation of circulating tumor cell clusters in meshed microwells

2022-07-05 - 2022-07

Extremely rare circulating tumor cell (CTC) clusters are both increasingly appreciated as highly metastatic precursors and virtually unexplored. Technologies are primarily designed to detect single CTCs and often fail to account for the fragility of clusters or to leverage cluster-specific markers for higher sensitivity.

Newsletter

© 2024 All Rights Reserved by Longdom